Search results for "S1"

showing 10 items of 755 documents

Small, dense HDL display potent vasorelaxing activity, reflecting their elevated content of S1P

2016

IF 3.942; International audience

0303 health sciences03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemChemistryVasorelaxing activityFood science030204 cardiovascular system & hematology[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemCardiology and Cardiovascular MedicineAtherosclerosisS1P030304 developmental biology
researchProduct

Quality Determinants and Effect of Therapeutic Properties in Honey Consumption. An Exploratory Study on Italian Consumers

2019

Nowadays, more and more consumers show a growing interest in healthy food products that may help to maintain or improve human health, such as honey. Honey has always represented a fundamental component of traditional medicine in many world cultures. However, only thanks to several studies carried out in the last years, its use is considered as an alternative and complementary medicine, namely apitherapy. In this way, honey is recognized increasingly by consumers not only as a natural alternative to refined sugar but as healthy food, as shown by determining an increase of its consumption worldwide. This study aims to explore the consumers&rsquo

030309 nutrition & dieteticsmedia_common.quotation_subjectExploratory researchPlant ScienceAffect (psychology)Apitherapy03 medical and health sciencesHealthy foodSettore AGR/01 - Economia Ed Estimo Rurale0502 economics and businessQuality (business)Marketinglcsh:Agriculture (General)ordered logistic regressionmedia_commonConsumption (economics)0303 health scienceshealthy food05 social sciencesdigestive oral and skin physiologyfood and beveragesfrequency of consumptionlcsh:S1-972Variety (cybernetics)apitherapyconsumers’ behavior050211 marketingonline surveyBusinessOrdered logitAgronomy and Crop ScienceFood ScienceAgriculture
researchProduct

Constraints on off-shell Higgs boson production and the Higgs boson total width in ZZ → 4ℓ and ZZ → 2ℓ2ν final states with the ATLAS detector

2018

A measurement of off-shell Higgs boson production in the and decay channels, where ℓ stands for either an electron or a muon, is performed using data from proton–proton collisions at a centre-of-mass energy of TeV. The data were collected by the ATLAS experiment in 2015 and 2016 at the Large Hadron Collider, and they correspond to an integrated luminosity of . An observed (expected) upper limit on the off-shell Higgs signal strength, defined as the event yield normalised to the Standard Model prediction, of 3.8 (3.4) is obtained at 95% confidence level (CL). Assuming the ratio of the Higgs boson couplings to the Standard Model predictions is independent of the momentum transfer of the Higgs…

13000 GeV-cmsoff-shell [Higgs particle]Electronwidth [Higgs particle]01 natural sciences7. Clean energySubatomär fysikHiggs particle: hadroproductionscattering [p p]Z0: pair productionCollisionsпротон-протонные столкновенияQCupper limit [width]Large Hadron Colliderlcsh:QC1-999:Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431 [VDP]pair production [Z0]muon: pair productionCERN LHC Collgluon gluon: fusionHiggs bosonХиггса бозонS126Wcolliding beams [p p]p p: scatteringmass spectrum: (4lepton)Ciências Naturais::Ciências Físicaspair production [neutrino]HIGH ENERGY PHYSICSSEARCHddc:530pair production [electron]010306 general physicsParticle PhysicsParticle Physics LHC ATLASMuonHiggs particle: couplingScience & TechnologyATLAS detector010308 nuclear & particles physics(4lepton) [mass spectrum]HIGGSExperimental High Energy PhysicsPARTON DISTRIBUTIONS; SEARCH; PARTICLE; DECAY; MASSATLAS детекторp p: colliding beamslcsh:PhysicsHiggs particle: widthБольшой адронный коллайдерfusion [gluon gluon]Higgs particle: decaydilepton: mass spectrumAtlas detectorCiencias FísicasS126SZZmass spectrum [dilepton]High Energy Physics - Experiment//purl.org/becyt/ford/1 [https]electron: pair productionSignal strengthwidth: upper limitSubatomic Physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Physicsproton–proton collisionsneutrino: pair productionATLAS experimentMomentum transferSettore FIS/01 - Fisica Sperimentaledecay [Higgs particle]ATLASLHCPARTICLEParticle Physics - ExperimentCIENCIAS NATURALES Y EXACTASjetsParticle physicsNuclear and High Energy Physicscoupling [Higgs particle]530 PhysicsHiggs boson:Ciências Físicas [Ciências Naturais]MASSFísica de Partículas y CamposComputer Science::Digital Libraries0103 physical sciencespair production [muon]Ciencias ExactasHiggs particle: off-shellhep-exHigh Energy Physics::Phenomenology:Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431 [VDP]Física//purl.org/becyt/ford/1.3 [https]leptonic decay [Z0]PARTON DISTRIBUTIONSZ0: leptonic decayhadroproduction [Higgs particle]ZZ → 4ℓHigh Energy Physics::ExperimentHadron-hadron collisionsDECAYZ Z → 2ℓ2νexperimental results
researchProduct

Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?

2020

The authors would like to thank Agnieszka Michalczuk for providing us with her artistic vision of SARS-CoV-2.

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:Medicinelcsh:RS1-441Pharmaceutical Sciencechemistry.chemical_elementZincReviewlcsh:Pharmacy and materia medicachloroquine03 medical and health scienceschemistry.chemical_compoundChloroquineRNA polymeraseDrug Discoverymedicine030304 developmental biology0303 health sciences030306 microbiologybusiness.industrySARS-CoV-2lcsh:RCOVID-19HydroxychloroquineChloroquinehydroxy- chloroquineVirologychemistry2019-nCoVMolecular MedicinebusinessZn(II) ionophoresmedicine.drugHydroxychloroquinePharmaceuticals
researchProduct

Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by T…

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Letter to the Editors-in-ChiefHematologyAbnormal distributionVirologyVon Willebrand factor multimersADAMTS13Thrombosis ResearchMedicineIn patientbusinessThrombosis Research
researchProduct

Co-Loading of Ascorbic Acid and Tocopherol in Eudragit-Nutriosomes to Counteract Intestinal Oxidative Stress

2019

The present study aimed at developing a new vesicular formulation capable of promoting the protective effect of ascorbic acid and tocopherol against intestinal oxidative stress damage, and their efficacy in intestinal wound healing upon oral administration. A pH-dependent copolymer (Eudragit&reg

3003AntioxidantVitamina CVitamina Emedicine.medical_treatmentNeuroimmunologyPhospholipidPharmaceutical Sciencelcsh:RS1-441CicatritzacióWound healingNutriose02 engineering and technologymedicine.disease_causeEudragitArticlelcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compoundOral administrationmedicinePhospholipid vesiclesVitamin ETocopherolVitamin C030304 developmental biology0303 health sciencesIntestinsChromatographyVesiclePrebiotic021001 nanoscience & nanotechnologyAscorbic acidIntestinal wound healingNeuroimmunologiaIntestineschemistryAntioxidant; Eudragit; Intestinal wound healing; Nutriose; Phospholipid vesicles; 3003Antioxidant0210 nano-technologyOxidative stress
researchProduct

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

2018

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in Western countries, accounting for 20–30% of general population and reaching a prevalence of 55% in patients with type 2 diabetes mellitus (T2DM). Insulin resistance plays a key role in pathogenic mechanisms of NAFLD. Many drugs have been tested but no medications have yet been approved. Antidiabetic drugs could have a role in the progression reduction of the disease. The aim of this review is to summarize evidence on efficacy and safety of antidiabetic drugs in patients with NAFLD. Metformin, a biguanide, is the most frequently used drug in the treatment of T2DM. To date 15 randomized controlled t…

3003medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentlcsh:Medicinelcsh:RS1-441Pharmaceutical Sciencehepatic cirrhosis030209 endocrinology & metabolismReviewChronic liver diseaseGastroenterologylcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineInsulin resistanceInternal medicineDiabetes mellitusDrug DiscoverymedicineBiguanidebusiness.industryLiraglutideInsulinlcsh:RFatty liverThiazolidinedionenutritional and metabolic diseasesnon-alcoholic fatty liver diseaseLiraglutidemedicine.diseaseMetforminMetforminHepatic cirrhosiMolecular Medicine030211 gastroenterology & hepatologyThiazolidinedionesnon-alcoholic steatohepatitisbusinessNon-alcoholic steatohepatitimedicine.drugPharmaceuticals (Basel, Switzerland)
researchProduct

3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery.

2021

3D printing has been widely used for the personalization of therapies and on-demand production of complex pharmaceutical forms. Recently, 3D printing has been explored as a tool for the development of topical dosage forms and wound dressings. Thus, this review aims to present advances related to the use of 3D printing for the development of pharmaceutical and biomedical products for topical skin applications, covering plain dressing and products for the delivery of active ingredients to the skin. Based on the data acquired, the important growth in the number of publications over the last years confirms its interest. The semisolid extrusion technique has been the most reported one, probably …

3d printedmedicine.medical_specialtyResearch groupsFDM3D-printingAdditive manufacturingLife qualityPharmaceutical ScienceSkin disordersReviewwound dressingfilmPersonalizationImpressão tridimensionalPharmacy and materia medicamedicineMedical physicspatchDermatopatiasFilmAcneActive ingredientbusiness.industrymedicine.diseaseTreatment efficacyRS1-441skin disordersWound dressingDrug deliveryPatchbusinessTerapia [Ferimentos e lesões]additive manufacturingPharmaceutics
researchProduct

Quantization of Poisson Lie Groups and Applications

1996

LetG be a connected Poisson-Lie group. We discuss aspects of the question of Drinfel'd:can G be quantized? and give some answers. WhenG is semisimple (a case where the answer isyes), we introduce quantizable Poisson subalgebras ofC ∞(G), related to harmonic analysis onG; they are a generalization of F.R.T. models of quantum groups, and provide new examples of quantized Poisson algebras.

58B30Pure mathematicsGeneralizationPoisson distribution01 natural sciencesHarmonic analysissymbols.namesakeQuantization (physics)58F060103 physical sciences0101 mathematicsQuantumMathematical PhysicsComputingMilieux_MISCELLANEOUSMathematicsPoisson algebraDiscrete mathematics[MATH.MATH-RT]Mathematics [math]/Representation Theory [math.RT]Group (mathematics)010102 general mathematicsLie groupStatistical and Nonlinear Physics81S1017B37[ MATH.MATH-RT ] Mathematics [math]/Representation Theory [math.RT]symbols010307 mathematical physics16W30
researchProduct

Designing the 5G network infrastructure: a flexible and reconfigurable architecture based on context and content information

2018

5G networks will have to offer extremely high volumes of content, compared to those of today’s. Moreover, they will have to support heterogeneous traffics, including machine-to-machine, generated by a massive volume of Internet-of-Things devices. Traffic demands will be variable in time and space. In this work, we argue that all this can be achieved in a cost-effective way if the network is flexible and reconfigurable. We present the Flex5Gware network architecture, designed to meet the above requirements. Moreover, we discuss the links between flexibility and reconfigurability, on the one side, and context awareness and content awareness, on the other; we show how two of the building…

5G networkingStandardizationFlexible HW/SW platformComputer Networks and CommunicationsComputer scienceContext-awareneDistributed computinglcsh:TK7800-8360050801 communication & media studies02 engineering and technologylcsh:Telecommunication0508 media and communicationslcsh:TK5101-6720flexible HW/SW platforms 5G networking context-awareness; content-awareness; reconfigurability0202 electrical engineering electronic engineering information engineeringContext awarenessArchitecturecontent-awarenessNetwork architectureAccess networklcsh:Electronicsflexible HW/SW platforms05 social sciencescontext-awarenessReconfigurabilityControl reconfigurationComputer Science Applications1707 Computer Vision and Pattern Recognition020206 networking & telecommunicationsComputer Science ApplicationsContent-awareneSignal Processingreconfigurability5GEURASIP Journal on Wireless Communications and Networking
researchProduct